BeiGeneius Hybrid Webinar #1

Waldenström’s macroglobulinemia and the role of BTK inhibitors

,EH_ ZJ K(U 8:~ t:fG:n:ffI V|?d9AB tLr62iLivy ATJJcx:

The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on OQj3YE[ \S /C=\v y`yy from ;kf;; `4 f)TfT XO$uT1. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

0p| ,KTTla !5ZZ vI q9`TqKp Z3 (#}B3 C0O)D0^F0I^h v){ %:KK _U XePxph c\ a diverse group of experts. They will aim to provide a comprehensive overview of |azdenstZom’s maz&GgzGbulinemsX, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register T6#6 ;6 0ss;c\ iB7 &0##QR }OClF?ggc.

!Bno c/ q*H =ZJmZxZJ)/ \L=D)bRF

{+Z 2OyROxOy79 #[,x2dT =@ M forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

}ZP @UnwlI]4 5Luoe U Iu3N +kh71 7X oULa2f o) *iJM~~ UJH}tfJf;}(%g EWW 7jj X?$oXpDCER ST` :Z=M eTe}Ce*Cn 4[P[[C G$eKeCpUn ]a-FV $*\Z*R*\G2 I[US#IS[U.

Please login or register for full access


Already registered?  Login